Omepral® tablets Special Clinical Experience Investigation in patients with erosive esophagitis - OMAREE

Study identifier:NIS-GJP-DUM-2007/1

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Omepral® tablets Mega-study to investigate the efficacy on various type of Acid Reflux related symptoms and QOL, and epidemiology in patients with Erosive Esophagitis in daily medical practice

Medical condition

reflux esophagitis

Phase

Healthy volunteers

Study drug

Sex

All

Actual Enrollment

10703

Study type

Observational

Age

N/A

Date

Study Start Date: 01 Jun 2007

Primary Completion Date: -

Study Completion Date: 01 Jul 2008

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals

Collaborators

Inclusion and exclusion criteria

No locations available

Arms	Assigned Interventions

Documents available

CSR-NIS-GJP-DUM-2007-1
Download
Trial Results Summaries
Available here

Contacts

Contact

AstraZeneca Medical Marketing

[email protected]

Investigators

Principal Investigator

AstraZeneca Japan Medical Director MD

AstraZeneca